Wolf K, Castrop H, Hartner A, Goppelt-Strübe M, Hilgers K F, Kurtz A
Institut für Physiologie, Universität Regensburg, Germany.
Hypertension. 1999 Sep;34(3):503-7. doi: 10.1161/01.hyp.34.3.503.
The expression of cyclooxygenase 2 (COX-2) in the late thick ascending limb, including the macula densa, is found to be upregulated in an activated renin-angiotensin system. How this upregulation is managed is not yet known. We therefore considered the possibility that the stimulation of COX-2 expression is triggered by the activation of the renin-angiotensin system. For this purpose, we treated male Sprague-Dawley rats with the angiotensin I-converting enzyme inhibitor ramipril (10 mg/kg per day), the angiotensin II type 1 (AT(1)) receptor blocker losartan (30 mg/kg per day), and the angiotensin II type 2 (AT(2)) receptor blocker PD123319 (6 mg/kg per day) for 4 days. We determined the expression of COX-2 mRNA and protein in the renal cortex. We found that ramipril and the AT(1) receptor blocker losartan increased COX-2 mRNA and COX-2 immunoreactivity in the macula densa approximately 4-fold, whereas the AT(2) blocker PD123319 showed no effect. A low-salt diet (0.02% wt/wt) stimulated COX-2 expression in the kidney cortex <2-fold. The combination of a low-salt diet with ramipril led to a further increase of COX-2 mRNA and COX-2 immunoreactivity compared with low salt or ramipril alone. These data indicate that endogenous angiotensin II apparently inhibits COX-2 expression in the macula densa via AT(1) receptors and can therefore not account for the stimulation of COX-2 expression associated with an activated renin-angiotensin system. Because macula densa-derived prostaglandins are considered stimulators of renin secretion and renin synthesis, inhibition of macula densa COX-2 by angiotensin II could form a novel indirect negative feedback control of the renin system.
在包括致密斑在内的髓袢升支粗段晚期,发现环氧合酶2(COX-2)的表达在激活的肾素-血管紧张素系统中上调。这种上调是如何调控的尚不清楚。因此,我们考虑了肾素-血管紧张素系统激活触发COX-2表达刺激的可能性。为此,我们用血管紧张素I转换酶抑制剂雷米普利(每天10mg/kg)、血管紧张素II 1型(AT(1))受体阻滞剂氯沙坦(每天30mg/kg)和血管紧张素II 2型(AT(2))受体阻滞剂PD123319(每天6mg/kg)处理雄性Sprague-Dawley大鼠4天。我们测定了肾皮质中COX-2 mRNA和蛋白的表达。我们发现雷米普利和AT(1)受体阻滞剂氯沙坦使致密斑中的COX-2 mRNA和COX-2免疫反应性增加了约4倍,而AT(2)阻滞剂PD123319则无作用。低钠饮食(0.02%重量/重量)使肾皮质中的COX-2表达增加不到2倍。与单独的低钠饮食或雷米普利相比,低钠饮食与雷米普利联合使用导致COX-2 mRNA和COX-2免疫反应性进一步增加。这些数据表明,内源性血管紧张素II显然通过AT(1)受体抑制致密斑中的COX-2表达,因此不能解释与激活的肾素-血管紧张素系统相关的COX-2表达刺激。由于致密斑衍生的前列腺素被认为是肾素分泌和肾素合成的刺激物,血管紧张素II对致密斑COX-2的抑制可能形成肾素系统一种新的间接负反馈控制。